Drug Target Insights (Jan 2008)

Memantine: Reality and Potentiality

  • Rita Moretti M.D.,
  • Paola Torre,
  • Cristina Vilotti,
  • Davide Manganaro,
  • Luca Zanet,
  • Rodolfo M. Antonello

DOI
https://doi.org/10.4137/DTI.S622
Journal volume & issue
Vol. 3

Abstract

Read online

Memantine protects cultured neurons from excitotoxin-induced cell-death; it attenuated loss of cholinergic neurons in the CNS induced by injection of NMDA into the basal forebrain of rats. It has been shown that memantine induced production of brain-derived neurotrophic factor (BDNF), a substance shown to promote survival and differentiation of CNS neuron. Due to the preclinical effects of memantine owing to its anti-ischemic and anti-excitotoxic properties, recent clinical efficacy has been demonstrated in patients with advanced dementia of vascular origins. Therefore, it has been employed in different trials, in vascular dementia, showing a potential benefit and no unbearable side effects. Different studies underline the possible role of memantine in Parkinson Disease.